These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35981764)

  • 1. A Comparison of US Medicare Expenditures for Hemodialysis and Peritoneal Dialysis.
    Kaplan JM; Niu J; Ho V; Winkelmayer WC; Erickson KF
    J Am Soc Nephrol; 2022 Nov; 33(11):2059-2070. PubMed ID: 35981764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis Versus Peritoneal Dialysis Drug Expenditures: A Comparison Within the Private Insurance Market.
    Bhatnagar A; Niu J; Ho V; Winkelmayer WC; Erickson KF
    Kidney Med; 2023 Aug; 5(8):100678. PubMed ID: 37455793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring kidney dialysis costs in the United States: a scoping review.
    Stewart F; Kistler K; Du Y; Singh RR; Dean BB; Kong SX
    J Med Econ; 2024; 27(1):618-625. PubMed ID: 38605648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hidden Costs Associated with Conversion from Peritoneal Dialysis to Hemodialysis.
    Weinhandl ED; Saffer TL; Aragon M
    Kidney360; 2022 May; 3(5):883-890. PubMed ID: 36128476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients.
    Shih YC; Guo A; Just PM; Mujais S
    Kidney Int; 2005 Jul; 68(1):319-29. PubMed ID: 15954923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Peritoneal Dialysis Use in the United States after Medicare Payment Reform.
    Sloan CE; Coffman CJ; Sanders LL; Maciejewski ML; Lee SD; Hirth RA; Wang V
    Clin J Am Soc Nephrol; 2019 Dec; 14(12):1763-1772. PubMed ID: 31753816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenging Assumptions of Outcomes and Costs Comparing Peritoneal and Hemodialysis.
    Lin E; Lung KI; Chertow GM; Bhattacharya J; Lakdawalla D
    Value Health; 2021 Nov; 24(11):1592-1602. PubMed ID: 34711359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial implications to Medicare from changing the dialysis modality mix under the bundled prospective payment system.
    Liu FX; Walton SM; Leipold R; Isbell D; Golper TA
    Perit Dial Int; 2014; 34(7):749-57. PubMed ID: 25292402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home Dialysis Utilization Among Racial and Ethnic Minorities in the United States at the National, Regional, and State Level.
    Wallace EL; Lea J; Chaudhary NS; Griffin R; Hammelman E; Cohen J; Sloand JA
    Perit Dial Int; 2017 1-2; 37(1):21-29. PubMed ID: 27680759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The financial implications for Medicare of greater use of peritoneal dialysis.
    Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
    Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Insurance and the Use of Peritoneal Dialysis in the United States.
    Perez JJ; Zhao B; Qureshi S; Winkelmayer WC; Erickson KF
    Am J Kidney Dis; 2018 Apr; 71(4):479-487. PubMed ID: 29277511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare's New Prospective Payment System on Facility Provision of Peritoneal Dialysis.
    Wang V; Coffman CJ; Sanders LL; Lee SD; Hirth RA; Maciejewski ML
    Clin J Am Soc Nephrol; 2018 Dec; 13(12):1833-1841. PubMed ID: 30455323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing Mortality of Peritoneal and Hemodialysis Patients in an Era of Medicare Payment Reform.
    Wang V; Coffman CJ; Sanders LL; Hoffman A; Sloan CE; Lee SD; Hirth RA; Maciejewski ML
    Med Care; 2021 Feb; 59(2):155-162. PubMed ID: 33234917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodialysis access cost comparisons among incident tunneled catheter patients.
    Wagner JK; Fish L; Weisbord SD; Yuo TH
    J Vasc Access; 2020 May; 21(3):308-313. PubMed ID: 31495265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of urgent-start peritoneal dialysis versus urgent-start hemodialysis in the United States.
    Liu FX; Ghaffari A; Dhatt H; Kumar V; Balsera C; Wallace E; Khairullah Q; Lesher B; Gao X; Henderson H; LaFleur P; Delgado EM; Alvarez MM; Hartley J; McClernon M; Walton S; Guest S
    Medicine (Baltimore); 2014 Dec; 93(28):e293. PubMed ID: 25526471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic costs of automated and continuous ambulatory peritoneal dialysis in Taiwan: a combined survey and retrospective cohort analysis.
    Tang CH; Wu YT; Huang SY; Chen HH; Wu MJ; Hsu BG; Tsai JC; Chen TH; Sue YM
    BMJ Open; 2017 Mar; 7(3):e015067. PubMed ID: 28325860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Patient Survival Between Hemodialysis and Peritoneal Dialysis Among Patients Eligible for Both Modalities.
    Wong B; Ravani P; Oliver MJ; Holroyd-Leduc J; Venturato L; Garg AX; Quinn RR
    Am J Kidney Dis; 2018 Mar; 71(3):344-351. PubMed ID: 29174322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial implications of choice of dialysis type of the revised Medicare payment system: an economic analysis.
    Hornberger J; Hirth RA
    Am J Kidney Dis; 2012 Aug; 60(2):280-7. PubMed ID: 22560829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
    Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
    Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of CMS pre-ESRD Kidney Disease Education services and its associations with the home dialysis therapies.
    Shukla AM; Bozorgmehri S; Ruchi R; Mohandas R; Hale-Gallardo JL; Ozrazgat-Baslanti T; Orozco T; Segal MS; Jia H
    Perit Dial Int; 2021 Sep; 41(5):453-462. PubMed ID: 33258420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.